Use of whole-genome sequencing to distinguish relapse from reinfection in a completed tuberculosis clinical trial

被引:0
作者
Adam A. Witney
Anna L. E. Bateson
Amina Jindani
Patrick P. J. Phillips
David Coleman
Neil G. Stoker
Philip D. Butcher
Timothy D. McHugh
机构
[1] St George’s University of London,Institute for Infection and Immunity
[2] UCL Centre for Clinical Microbiology,undefined
[3] Royal Free Campus,undefined
[4] UCL,undefined
[5] MRC Clinical Trials Unit at UCL,undefined
来源
BMC Medicine | / 15卷
关键词
Whole genome sequencing; Tuberculosis; Clinical trial;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 184 条
[1]  
Fox W(1999)Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications Int J Tuberc Lung Dis 3 S231-279
[2]  
Ellard GA(1990)Insertion element IS986 from Mycobacterium tuberculosis: a useful tool for diagnosis and epidemiology of tuberculosis J Clin Microbiol 28 2051-8
[3]  
Mitchison DA(2006)Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis J Clin Microbiol 44 4498-510
[4]  
Hermans PW(1997)Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology J Clin Microbiol 35 907-14
[5]  
van Soolingen D(1993)Application of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapy Tuber Lung Dis 74 47-51
[6]  
Dale JW(2000)Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Interim report: no activity of isoniazid in the continuation phase Int J Tuberc Lung Dis 4 262-7
[7]  
Schuitema AR(2002)Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial Lancet 360 528-34
[8]  
McAdam RA(2011)Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: the Study C randomized controlled trial JAMA 305 1415-23
[9]  
Catty D(2004)Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial Lancet 364 1244-51
[10]  
Supply P(2013)Contact investigations for outbreaks of Mycobacterium tuberculosis: advances through whole genome sequencing Clin Microbiol Infect 19 796-802